Issuer

Tatva Chintan Pharma IPO

16th - 20th Jul 2021

Price Band

₹1073 to ₹1083

Issue Size

₹500 Cr

Face Value

₹10 per share

Market Lot

13 Shares

About Tatva Chintan Pharma IPO

Incorporated in 1996, Tatva Chintan Pharma Chem Limited is a chemical manufacturing company that manufactures structure directing agents (SDAs), phase transfer catalyst (PTCs), pharmaceutical and agrochemical intermediates, and other specialty chemicals. It is among the largest manufacturer of SDAs for zeolites in India.

The company serves customers across industries i.e. automotive, petroleum, agrochemicals, dyes and pigments, paints and coatings, pharmaceutical, personal care, and others. Its products are not only sold in India but also export to 25+ countries all over the world such as the USA, Germany, South Africa, China, and the UK. In FY 2020, total export contributed to 76% of total revenue from operations.

Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi's laboratories are a few of customers of the company. Currently, it has two manufacturing facilities at Ankleshwar and Dahej in Gujarat.

Competitive Strength

  • Leading manufacturer of structure directing agents and phase transfer catalyst.
  • Diversified product portfolio.
  • Global market presence with customer base across industries.
  • Strategically located manufacturing facility in Gujarat with close proximity to Hazira Port.
  • Experienced promoters and managers team.
  • Strong financial performance track record.

Objects of the Issue

  • Funding capital expenditures requirements for expansion of Dahej manufacturing facility.
  • Funding capital expenditures requirements to upgrade R&D facilities in Vadodara.
  • To meet general corporate purposes.

Tatva Chintan Pharma IPO Details

IPO Opening Date Jul 16, 2021
IPO Closing Date Jul 20, 2021
Issue Type Book Built Issue IPO
Face Value ₹10 per equity share
IPO Price ₹1073 to ₹1083 per equity share
Market Lot 13 Shares
Min Orher Quantity 13 Shares
Listing At BSE, NSE
Issue Size [.] Eq Shares of ₹10 (aggregating up to ₹500.00 Cr)
Fresh Issue [.] Eq Shares of ₹10 (aggregating up to ₹225.00 Cr)
Offer for Sale [.] Eq Shares of ₹10 (aggregating up to ₹275.00 Cr)

Tatva Chintan Pharma IPO Tentative Timetable

The Tatva Chintan Pharma IPO open date is Jul 16, 2021, and the close date is Jul 20, 2021. The issue may list on Jul 29, 2021.

IPO Open Date Jul 16, 2021
IPO Close Date Jul 20, 2021
Basis of Allotment Date Jul 26, 2021
Initiation of Refunds Jul 27, 2021
Credit of Shares to Demat Account Jul 28, 2021
IPO Listing Date Jul 29, 2021

Tatva Chintan Pharma IPO FAQs

What is Tatva Chintan Pharma IPO?

Tatva Chintan Pharma IPO is a main-board IPO of [.] equity shares of the face value of ₹10 aggregating up to ₹500.00 Crores. The issue is priced at ₹1073 to ₹1083 per equity share. The minimum order quantity is 13 Shares. The IPO opens on Jul 16, 2021, and closes on Jul 20, 2021. Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

When Tatva Chintan Pharma IPO will open?

The Tatva Chintan Pharma IPO opens on Jul 16, 2021 and closes on Jul 20, 2021.

What is the lot size of Tatva Chintan Pharma IPO?

Tatva Chintan Pharma IPO lot size is 13 Shares and the minimum order quantity is 13 Shares.

How to apply for Tatva Chintan Pharma IPO?

You can apply in Tatva Chintan Pharma IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services.

When Tatva Chintan Pharma IPO allotment?

The finalization of Basis of Allotment for Tatva Chintan Pharma IPO will be done on Jul 26, 2021, and the allotted shares will be credited to your demat account by Jul 28, 2021. (https://kcas.kfintech.com/ipostatus/)

When is Tatva Chintan Pharma IPO listing date?

The Tatva Chintan Pharma IPO listing date is not yet announced. The tentative date of Tatva Chintan Pharma IPO listing is Jul 29, 2021.

Top 5 Reasons to Open a Demat A/c With SMC

Zero Account Opening Charges

Pay nil account opening charge for an integrated demat and online trading A/c.

Free Expert Investment Advice

Get free stock ideas and research reports from India’s award winning research desk.

Open an A/c in Just 15 Minutes

Forget the hassle of physical forms and with eKYC open an A/c in 15 mins.

Next-Gen Trading App

Trade with a powerful, feature rich and easy to use trading app across web, mobile and desktop.

One Stop Investment Shop

Invest & trade in shares, mutual funds, IPOs, commodities & currency from a single interface.